Baseline severity and early tacrolimus trough are associated with time to minimal manifestations in steroid-free tacrolimus monotherapy for AChR antibody-positive myasthenia gravis
Baseline severity and early tacrolimus trough are associated with time to minimal manifestations in steroid-free tacrolimus monotherapy for AChR antibody-positive myasthenia gravis. // Virology. – URL: https://www.sciencedirect.com/science/article/pii/S0035378726006387?dgcid=rss_sd_all
Baseline severity and early tacrolimus trough are associated with time to minimal manifestations in steroid-free tacrolimus monotherapy for AChR antibody-positive myasthenia gravis. Virology. https://www.sciencedirect.com/science/article/pii/S0035378726006387?dgcid=rss_sd_all
“Baseline severity and early tacrolimus trough are associated with time to minimal manifestations in steroid-free tacrolimus monotherapy for AChR antibody-positive myasthenia gravis.” Virology.
@article{article13118,
title = {Baseline severity and early tacrolimus trough are associated with time to minimal manifestations in steroid-free tacrolimus monotherapy for AChR antibody-positive myasthenia gravis},
journal = {Virology},
url = {https://www.sciencedirect.com/science/article/pii/S0035378726006387?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Morphologie, Volume 110, Issue 371 Author(s): D. Irismetova, M. Tolibov, S. Saloydinov, U. Madatov, I. Nurmatova
Publication date: December 2026 Source: Morphologie, Volume 110, Issue 371 Author(s): A. Merí-Vived, P.V. López Plaza, A. Morral Fernández, M. Llusá-Pérez, M. García-Cuesta, A. Casado Rodríguez